target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id "lipase G, endothelial type",2591,Q9Y5X9,Human,GSK-264220A,6697,,2810413,O=C(Nc1ccccc1)Nc1cc(oc1C)S(=O)(=O)N1CCCCC1,"InChI=1S/C17H21N3O4S/c1-13-15(19-17(21)18-14-8-4-2-5-9-14)12-16(24-13)25(22,23)20-10-6-3-7-11-20/h2,4-5,8-9,12H,3,6-7,10-11H2,1H3,(H2,18,19,21)",LVOVQRPAMXCXTM-UHFFFAOYSA-N,Inhibitor,Irreversible inhibition,,,,,pIC50,,8.9,,IC50,,130.0,,,,,,19058966, "lipase G, endothelial type",2591,Q9Y5X9,Human,compound 12 [PMID: 31990537],10664,,90057968,O=C(c1nc2c(s1)cc(cc2)c1ccccc1)c1nnc(o1)CNS(=O)(=O)N,"InChI=1S/C17H13N5O4S2/c18-28(24,25)19-9-14-21-22-16(26-14)15(23)17-20-12-7-6-11(8-13(12)27-17)10-4-2-1-3-5-10/h1-8,19H,9H2,(H2,18,24,25)",LXSODRTWQNWTOG-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.3,,IC50,,5.0,,=,Determined in a fluorogenic substrate assay using recombinant human EL.,,,31990537,